FDA approves Pradaxa (dabigatran etexilate) to prevent stroke in people with atrial fibrillation

Tuesday, October 19, 2010

We now have a new class of oral anticoagulation medications on the market. Here's the news from the FDA:

The U.S. Food and Drug Administration today approved Pradaxa capsules (dabigatran etexilate) for the prevention of stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation).

Pradaxa is an anticoagulant that acts by inhibiting thrombin, an enzyme in the blood that is involved in blood clotting. The safety and efficacy of Pradaxa were studied in a clinical trial comparing Pradaxa with the anticoagulant warfarin. In the trial, patients taking Pradaxa had fewer strokes than those who took warfarin.

Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals Inc. of Ridgefield, Conn., will be available in 75 milligram and 150 milligram capsules.

Read more here.

Comments

No response to “FDA approves Pradaxa (dabigatran etexilate) to prevent stroke in people with atrial fibrillation”
Post a Comment | Post Comments (Atom)

Post a Comment

About Dr. Joseph Kim

My Photo
Dr. Joseph Kim is the founder of MedicineandTechnology.com, an independent website owned and operated by Dr. Kim. He is also the President of MCM Education, a professional medical education and publishing company that develops continuing medical education (CME) activities in joint sponsorship with medical universities, hospitals, and medical associations.

Dr. Kim is a digital entrepreneur and technologist who has a passion for health information technology, mobile health, and social media. He frequently speaks at conferences about non-clinical careers for physicians, continuing medical education, mobile health technology, and social media in medicine. He is a regular contributor for the Physician Executive Journal, the official journal of the American College of Physician Executives.

Dr. Kim holds a bachelor of science in engineering from the Massachusetts Institute of Technology, a doctorate of medicine from the University of Arkansas College of Medicine, and a master of public health from the University of Massachusetts Amherst School of Public Health.
View my complete profile
Blog Widget by LinkWithin